DI
USNA icon

Disciplined Investments’s Usana Health Sciences USNA Stock Holding History

Disciplined Investments’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2
Closed -$126 – 1727
2023
Q1 		$126 Buy
+2
New +$119 ﹤0.01% 1548
2022
Q3 		– Sell
-2
Closed – – 1633
2022
Q2 		$0 Hold
2
– – ﹤0.01% 1641
2022
Q1 		$0 Buy
+2
New +$180 ﹤0.01% 1633

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Disciplined Investments's USNA Position: Q2 2023 in Review

Disciplined Investments sold out of Usana Health Sciences (USNA) in Q2 2023, closing a stake of 2 shares — an estimated $126 sold.

Disciplined Investments first reported a position in USNA in Q1 2022 and held it in 3 quarters. The position peaked at $126 in Q1 2023. 169 funds tracked by Wall St. Rank hold USNA as of Q2 2023.

  • Disciplined Investments reported no remaining Usana Health Sciences position as of Q2 2023 after selling out during the quarter.
  • Disciplined Investments sold 2 Usana Health Sciences shares in Q2 2023, an estimated $126.
  • Disciplined Investments first reported a position in Usana Health Sciences in Q1 2022 and held it in 3 quarters.
  • Disciplined Investments's Usana Health Sciences position peaked at $126 in Q1 2023.
  • 169 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2023.

Based on Disciplined Investments's 13F filing for Q2 2023, filed 10 Jul 2023.